CA ATRA 10 mg Capsule

CA ATRA 10 mg Capsule contains 10 mg of tretinoin in each capsule. It is an anti-cancer medicine in the retinoid class, used in the treatment of acute promyelocytic leukemia (APL), a type of blood cancer. CA ATRA 10 mg Capsule is taken by mouth and is usually used as part of a doctor-directed cancer treatment plan. Because it is a 10 mg strength, it is a higher-dose capsule that should only be used when a clinician has determined it is appropriate.

How it works: Tretinoin helps immature leukemia cells mature into more normal cells, which can reduce the number of abnormal cells in the bloodstream and bone marrow. In CA ATRA 10 mg Capsule, the medicine is absorbed from the digestive tract after swallowing and then works throughout the body as directed by the treatment plan.

CA ATRA 10 mg Capsule is a higher-strength tretinoin capsule, so it is not a casual starting option and should be used only under specialist supervision. Compared with lower-strength tretinoin capsules, this 10 mg strength may let a doctor match the prescribed daily dose using fewer capsules, which can simplify dosing when a higher total amount is needed.

• Treatment of acute promyelocytic leukemia (APL)
• Part of induction therapy for APL
• Used with other cancer medicines as prescribed
• Doctor-supervised treatment for a blood cancer condition

• Swallow CA ATRA 10 mg Capsule whole with water; do not crush, open, or chew it.
• Take it exactly at the times your doctor prescribes, because the schedule is important for cancer treatment.
• Take the capsule with food or shortly after a meal if your prescriber directs, since food can help with absorption and stomach tolerance.
• Avoid handling broken capsules; if the capsule leaks, wash your hands and contact your pharmacist for advice.
• Do not change your dose on your own, even if symptoms improve or side effects occur.
• If you miss a dose, contact your oncology team for instructions instead of doubling up.

Each CA ATRA 10 mg Capsule provides 10 mg of tretinoin. The total daily dose and how often you take it are decided by your doctor based on your body size, lab results, and treatment goals; some patients may take multiple capsules per day to reach the prescribed dose, while others may need a different regimen. Do not take more than your oncology team instructs, because this is a high-risk cancer medicine and the dose must be individualized.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Tretinoin may include:

• Headache
• Dry skin or peeling skin
• Dry lips
• Mild nausea or vomiting
• Bone or muscle pain
• Fatigue
• Raised blood lipids or liver test changes

• CA ATRA 10 mg Capsule is a higher-strength tretinoin capsule and should be used only with oncology supervision.
• Tell your doctor if you are pregnant, could become pregnant, or are breastfeeding, because tretinoin can seriously harm an unborn baby.
• Use effective contraception as directed by your prescriber during treatment and for the recommended time afterward.
• This medicine can affect liver tests and blood fats, so blood work may be needed regularly.
• Report headache, vision changes, chest symptoms, fever, or sudden swelling right away.
• Tell your doctor about heart disease, high cholesterol, liver disease, or a history of blood clots before starting treatment.
• Avoid vitamin A supplements unless your doctor says they are okay, because they may increase toxicity.

• Vitamin A supplements and other retinoid medicines
• Tetracycline antibiotics, which may raise the risk of increased pressure in the head
• Drugs that affect the liver, including some antifungals and anticonvulsants
• Blood thinners or antiplatelet medicines, if your doctor is monitoring bleeding risk

Store CA ATRA 10 mg Capsule at room temperature in its original strip/box, away from moisture, heat, and direct light, and keep it out of reach of children.